Cyber Monday saleUp to 70% OFF

Earningsplay

SNOW pulls bak on Earnings Discount SaleSNOW on the daily chart pulled back from decent earnings to in a massive bearish candle down into its intermediate-term fair value zone near to the mean anchored VWAP and the POC line of the volume profile. It is entirely possible that many traders sold SNOW at its highs when they got FOMO over NVDA and needed to free capital to get more cash in their accounts after buying NVDA . This could have easily helped SNOW go down despite decent earnings. No matter if SNOW is on sale, I will buy it now setting a stop loss @ $145.00 and watch for a Fibonacci-style retracement halfway back to the Pirvot high from which it fell for a first the target of $ 170, a second of $180 ( one third of the position for each) and the final at $170. In the meanwhile, I have a position on NVDA to play a possible drop.
NYSE:SNOW
by AwesomeAvani
NVDA can it fall from the ceiling after EarningseOn the 2hr chart, NVDA popped from earnings over 20% putting with a PE Ratio sky high on the promise of semiconductor heaven and AI ecstasy. Can it stay there ? Will it lead other technology companies ( semiconductors / cloud services / AI et cetera) higher as well ? Is it now overbought and looking at a glass ceiling? The indictors suggest a near-term top, I think. ( Money Flow Index. Stochastic RSI ). Accordingly, I will buy put options striking $ 400 for expiration 7/21 and be quick to take profits expecting NVDA to equilibrate in less than a week. In th meanwhile, I will hdege by keeping my AMD and MU call options open figuring that they will jump up as copy cats of this move. I will cut them loose as soon as price action and a loss of volume suggest retracement as well. I see buyers who got in late with high FOMO to be the lad sellers fueling the put options into easy profit.
NASDAQ:NVDA
by AwesomeAvani
2
SYM Technology @ WorkSYM has ascended YTD at a rate of 20% monthly and compounded. It has had consistent earnings doing its thing which is providing robots to replace human labor in factories and servicing them. Its products are in constant demand and growing. On the chart, SYM is above the POC of the volume profile. Buyers have pushed the price higher and sellers overall have not kept up with opposing momentum. Price is in the upper bands of both the intermediate and short-term anchored VWAPs putting it in the fair to overvalued range. I see SYM as continuing to rise as companies and industries with warehouses seek to lower labor costs as a means to maintain their margins and survive the recession and its consequences. For me, this is an obvious long setup with high potential.
NASDAQ:SYMLong
by AwesomeAvani
Weak Trend Line and Bearish MACD Gap Indicate Potential ReversalNYSE:HD has profitable for the past five years, with earnings per share (EPS) growing at an average rate of 17.67%. The company also pays a dividend, which has been growing at an average rate of 16.37%. The company's valuation metrics are also relatively healthy, with a price-to-earnings ratio (P/E) of 17.355 and a price-to-book ratio of 205.99. However, there are a few areas of concern. First, the company's debt-to-equity ratio is high, at 96.411%. This means that the company is relying heavily on debt to finance its operations. Second, the company's inventory turnover ratio is low, at 4.4343. This means that the company is taking longer to sell its inventory than it should. The technical indicators are showing some intriguing signs the chart. A weak trend line on the buy signal combined with a hidden divergence suggests consolidation or choppy market conditions. Furthermore, a gap in the MACD histogram could be signaling a potential bearish reversal. The weak trend line on the buy signal suggests a lack of strong bullish momentum. This, coupled with the hidden divergence, could be indicating a phase of consolidation or choppy market conditions. During such periods, the market often moves sideways within a range, making it difficult for trend-based strategies to generate profits. The gap in the MACD histogram is another crucial factor to consider. Such gaps often precede reversals, indicating that the bears could be about to take control. This could be an excellent opportunity for traders looking to short sell or buy put options. The key levels to watch are: - Support at 287: This is where we can expect buying pressure to emerge. If the price drops to this level and then bounces, it could be a buying opportunity for short-term traders. - Resistance at 291.3: This is where we can expect selling pressure. If the price rises to this level and then starts to fall, it could be an opportunity for short selling or buying put options. In conclusion, the current chart presents a mixed outlook with indications of potential bearish reversal. Im looking to enter a short position if it breaks through the support line.
NYSE:HDShort
by TicksandWicks22
VRPX Biotechnology Penny Stock Post EarningsVRPX was on a downtrend from mid-February into a reversal the beginning of May. VRPX beat earnings up still has no cash flow which is very common in this subsector. VRPX is priced on the potential of future earnings. The short and long-moving averages ratio shows bullish momentum also shows strength with an upper Bollinger Band "walk". Price has climbed over the POC line so it is higher than the mean of the share price traded for the duration of the volume profile. I see this as a risky long setup expectant of a 40% profit based on the target of the YTD high in February.
NASDAQ:VRPXLong
by AwesomeAvani
BLUE Biotechnology New Earnings Catalyst LONGBlueBird Bio / BLUE had an earnigns report this past week showing earnings for the firat time but revenue was far below analyst's projections. Price has appreciated 40% in the 4 weeks since earnings which is about 500% annualized. GO BLUE. On the daily chart, price was above VWAP and consolidating much of last fall then dropped this YTD until the earnings report of last week. An uptrend is seen after the earnings. This has been a significant reversal sustained over the past month with price rising above the support / demand zone below it. At present, price is one standard deviation below VWAP making it undervalued and ascending. I see this as a risky long trade like many biotechology penny stocks but with a decent probability of profit in consideration of a target of 6.15 which is the top of the long term high volume area. the stop loss is just below the POC line of the volume profile at 3.15 An entry at 4.62 ( limit order above SMA200 (redlne) would yield at profit of 1.50 with a risk of 0.48 making for a R:R of 3:1. Another earnings report is coming up this week. If it is favorable, BLUE could go parabolic to hit the target in a day or two. If not, it will be time to exit the trade.
NASDAQ:BLUELong
by AwesomeAvani
7
Long Trade in HIMSHIMS has been a market-leading stock for several months. It has tripled since October and is now consolidating at all-time highs before its earnings announcement. The company is scheduled to report after market close on Monday, 5/9. If I were a gambler, my bet would be that they beat and surge higher. Personally, I’m not willing to risk it which is why I recently covered my position in HIMS for a quick profit. But if Monday’s numbers are good, I will consider buying back in on Tuesday morning.
NYSE:HIMSLong
by rossgivens
MRNA ? Buy Weakness MRNA descended this past winter off a head-and-shoulders pattern on the daily chart just under the demand zone as shown by the LuxAlgo indicator. Price is now in a downtrend heading into earnings tomorrow. MRNA needs to show something good otherwise it will break through the demand zone and keep going down. This is a risky earnings play betting that something will show up on the report to buoy up the company and its stock. I will risk 0.01% of the trading account on a call option with DTE 5/19/23 looking for a minor surge and so a good quick profit. ( see also the link below)
NASDAQ:MRNALong
by AwesomeAvani
Z Zillow Group Options Ahead of EarningsIn my opinion, Zillow, a well-known online real estate platform, is poised to witness a significant drop in revenue this quarter due to various factors. Firstly, there seems to be a lack of interest among potential customers in utilizing their services. Additionally, with interest rates currently high, it is possible that fewer people will be interested in purchasing homes, which could further impact Zillow's revenue. These challenges, along with other market factors, make it a tough quarter for Zillow, and the company will need to navigate these challenges carefully to maintain their market position. Now analyzing the options chain of Z Zillow Group prior to the earnings report this week, I would consider purchasing the 40usd strike price Puts with an expiration date of 2023-12-15, for a premium of approximately $4.35. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. I am interested to hear your thoughts on this strategy.
NASDAQ:ZShort
by TopgOptions
ABT Abbott Labs Med Tech Short Setting UpABT is shown on a 4H chart as setting up for a short trade. Demand and Summply Zones are charted by the LuxAlgo indicator. Price touched the supply zone five times in December- January then descended and touched the demand zone several times in mid-March. Fundamentally, earnings reports have been solid. Medical stocks are generally independent of the economy and recession resilient. ABT has risen off the base of bottoms at support . Relative volume exceeds that of the past year showing investor/trader interest has increased. I think it will progress to touch the supply / resistance zone another once or twice and then reverse into a solid downtrend. I see this as worth watching this upcoming week for the reversal.
NYSE:ABTShort
by AwesomeAvani
Intapp INTA Cloud Software Services Tech LONG As can be seen on the 2H Chart INTA is on pacing over a 350% annualized gain without any major pivots. The volume indicator shows a dramatic increase in volume realtive to the year prior. INTA is capturing alpha consistently in a hypergrowth mode as can be seen by reviewing the earnings beats quarter after quarter. This is clear and obvious entry with earnings coming on May 8th. I originally bought options last summer after the double bottom and have added a couple of weeks before each earnings . Price recently bounced down 10% from minor resistance representing a small pullback with space above in the runup for the earnings report. I see a potential return of 15% in 10 trading days or less and 75-100% for call options with expiration of 5/19/23 in consideration of the pullback described above and shown on the chart
NASDAQ:INTALong
by AwesomeAvani
VZ Verizon Communications Options Ahead of EarningsIf you haven sold VZ here: Then analyzing the options chain of VZ Verizon Communications prior to the earnings report this week, I would consider purchasing the 37usd strike price Puts with an expiration date of 2023-5-19 for a premium of approximately $0.84 If these options prove to be profitable prior to the earnings release, I would sell at least half of them. I am interested to hear your thoughts on this strategy.
NYSE:VZShort
by TopgOptions
APLT Biotech NASDAQ Penny LONGApplied Therapeutics is an uptrending biotechnology company that has earnings in prior quarters and is heading into another earnings report about may 11th. The run up in price cction is largely on the proposition of future growth much like TSLA back in the day. On the chart besides the obvious uptrend, the volume indicator shows a dramatic volume surge compared with the running 50 day average while the MACD shows the lines above the histogram and running upward and parallel. The ideal entry would be a pullback as the price is now quite extended however I do not believe that will occur until at least after earnings. I believe this strong runner will continue until earnings unabated. As a penny stock many shares can be taken and then the position can be closed in partials along the way thus taking profits and decreasing the risk in steps. The same applies to the call options.
NASDAQ:APLT
by AwesomeAvani
1
Dancing on the Ceiling In recent days, a variety of technology stocks have surged as a result of robust earnings reports. Microsoft's impressive cloud and AI performance have been particularly noteworthy, leading to a ~8% increase in its stock value. The company was on the verge of breaking its single-day record for market capitalization growth. In contrast, cryptocurrency markets have experienced a far more substantial upswing than equities over the past few days. Bitcoin has once again spearheaded the crypto rally, as expectations for future rate hikes dropped substantially due to continuing cracks in the regional banking system. However, this time, the change in the narrative was triggered by a larger-than-anticipated decline in deposits for First Republic (FRC), which has inflicted severe damage on FRC’s balance sheet and will be difficult to overcome. On Tuesday, FRC's stock plunged by about 49%, followed by another 25% drop on Wednesday morning. In other news, the ongoing U.S. debt ceiling crisis presents a compelling and potentially precarious situation that warrants close attention. Earlier in January, the U.S. government reached its borrowing limit and has since relied on "extraordinary measures" to manage its cash flow due to the absence of new treasury issuances. As a result, the Treasury's cash balance has been steadily decreasing this year, and financial markets are becoming increasingly concerned as funds are expected to run out by June, potentially leading the government to default on its debt obligations. This scenario merits close monitoring, as evidence suggests that a technical default could trigger contagion effects, which, in a worst-case scenario, could potentially double the U.S. unemployment rate to around 7%. Furthermore, a divided Congress will make raising the debt ceiling particularly challenging for Democrats unless compromises are reached. Market apprehensions are evident in soaring credit default swap spreads—an indicator of the cost to protect against a U.S. government default—as well as the spread between 1-month and 3-month Treasury Bill yields (approximately 3.4% vs around 5.1%) widening. Recently investors have sought 1-month Treasury Bills that mature before the predicted exhaustion of government funds, causing the price of 1-month Bills to rise and their yield to fall. From a technical standpoint, Bitcoin has experienced a minor pullback from its local top of around HKEX:31 ,000 and has since tested the 50-day moving average before regaining some bullish momentum. In the event of another pullback, traders will likely watch for the 50-day moving average to serve as support once again. MA9 and MA50 are also beginning to converge, with a potential crossing of MA9 below MA50 imminent. This would be a bearish signal. When MA9 previously crossed above MA50, Bitcoin gained significant momentum, underscoring the importance of a potential crossing of MA9 below MA50. Looking ahead, key dates to monitor include May 3rd and 4th, when the upcoming FOMC meeting is scheduled. The Federal Reserve has already hinted at a further 25 basis point hike, which the market has likely priced in. Nonetheless, exercising caution is advisable, as the Fed may take unexpected actions during this meeting.
BINANCE:BTCUSD
by Coinrule
ACHV a Biotech company after earningsACHV on the 4H seems to be demonstrating a "High Bull Flag Pattern" after a big uptrend to start the year. Earnings on Thursday 3/16 were quite favorable.On the relative volume indicator Friday, May 17th showed a paradoxical huge selling volume spike to finish out this week. ( I mislabelled this as upcoming on the chart) Paradoxically, the last earnings report in November was poor but resulted in strong upward price action. The MACD histogram is at the zero line. Will ACHV resume the uptrend after earnings? Was the selling volume an institutional trader fake out to set up a lower price to buy call options? According to Tip Ranks, the analysts give ACHV a high rating with significant upside. See the link below Who knows but this may be worth watching for signs of buying volume and accumulation to fuel bullish momentum.
NASDAQ:ACHV
by AwesomeAvani
1